Celgene Corp. (CELG) reported third quarter adjusted EPS of $0.97 Thursday morning, up from $0.78 in the previous year. Analysts expected EPS of $0.95. The company also raised its full year adjusted EPS guidance to a range of $3.65 to $3.70, from the prior forecast of $3.60 to $3.65. The consensus estimate is for EPS of $3.67.
Celgene gapped up slightly Thursday and climbed throughout the first 2 hours of trade. The stock ended the day higher by 5.64 at $100.40 on above average volume. Celgene broke out of a 2-month range and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News